WO2022108595A1 - Compositions contenant des oméga-3 améliorées - Google Patents

Compositions contenant des oméga-3 améliorées Download PDF

Info

Publication number
WO2022108595A1
WO2022108595A1 PCT/US2020/061561 US2020061561W WO2022108595A1 WO 2022108595 A1 WO2022108595 A1 WO 2022108595A1 US 2020061561 W US2020061561 W US 2020061561W WO 2022108595 A1 WO2022108595 A1 WO 2022108595A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
weight
lipids
polar
fraction
Prior art date
Application number
PCT/US2020/061561
Other languages
English (en)
Inventor
Brian L. Goodall
Dmitry KUKLEV
Glen L. Bostick
Original Assignee
Nooter/Eriksen, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nooter/Eriksen, Inc. filed Critical Nooter/Eriksen, Inc.
Priority to JP2023530197A priority Critical patent/JP2023548424A/ja
Priority to MX2023005910A priority patent/MX2023005910A/es
Priority to CA3198736A priority patent/CA3198736A1/fr
Priority to IL303067A priority patent/IL303067A/en
Priority to EP20962632.4A priority patent/EP4247924A1/fr
Priority to KR1020237020521A priority patent/KR20230107344A/ko
Priority to PCT/US2020/061561 priority patent/WO2022108595A1/fr
Priority to CN202080108322.1A priority patent/CN116723827A/zh
Priority to AU2020477490A priority patent/AU2020477490A1/en
Publication of WO2022108595A1 publication Critical patent/WO2022108595A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A23L29/04—Fatty acids or derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/10—Production of fats or fatty oils from raw materials by extracting
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/001—Refining fats or fatty oils by a combination of two or more of the means hereafter
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/006—Refining fats or fatty oils by extraction
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/008—Refining fats or fatty oils by filtration, e.g. including ultra filtration, dialysis
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/10—Refining fats or fatty oils by adsorption
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B3/00—Refining fats or fatty oils
    • C11B3/12—Refining fats or fatty oils by distillation
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0007—Organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Definitions

  • Omega-3 oils are in high demand today due to aquaculture, fisheries and other marine sources only able to supply approximately 0.8 million tons of omega-3 fatty acids per year for human consumption. This is below the human nutritional demand of 1 .4 million tons required to supply the global population with 500 mg omega-3 fatty acids daily and will be further exacerbated by population growth. Omega-3 fatty acids deficiencies have been observed worldwide and particularly affect populations located in North America, central Europe, the Middle East, India, Brazil and the United Kingdom, with regional and socioeconomic differences seen within the countries. There are three major omega-3 fatty acids found in nature. Alpha linoleic acid (ALA), with 18 carbons and 3 double bonds, can be found, e.g., in flax seeds, soybean oil and olives.
  • ALA Alpha linoleic acid
  • DHA Docosahexaenoic acid
  • EPA Eicosapentaenoic acid
  • “Working algae”, i.e., algae grown using sunlight or artificial light and photosynthesis include lipids that are polar in nature, and while bioavailable, include other components which give the oil extracted therefrom an overall, very dark, nearly black-ish, appearance, and are also highly viscous, making them resemble a tar-like black solid.
  • An EPA-containing composition with an elevated bioavailability, which presents as a low viscosity, low chlorophyll content light amber to dark amber colored oil for use in nutraceutical and pharmaceutical products is currently unavailable, yet highly desirable.
  • the present disclosure relates to an elevated bioavailable, EPA-rich composition.
  • Starting material for this composition may be derived from algae.
  • a composition including a polar lipids fraction of a concentration of total lipids of at least 20% of the total lipids by weight%; wherein the polar lipids fraction comprises at least 30% glycolipids by weight; and wherein the composition comprises no greater than 4% of its weight% as a chlorophyll concentration.
  • the composition further comprises no greater than 4% of its weight% as a polysaccharide composition.
  • the above embodiments provides an attractive composition for use in both the nutraceutical and pharmaceutical fields in terms of reduced opacity and viscosity, as well as other beneficial attributes.
  • composition as described above with its total lipids having a fraction of at least 20 wt.% polar lipids, and its polar lipids having a fraction of at least 30 wt.% glycolipids, but the composition having less than a 4 wt.% chlorophyll fraction, may further include formulations with additive non-polar lipids and/or nutraceutical oils such as DHA, or other beneficial additives as more fully described below, which also assist in providing for certain beneficial combinations of a more bioavailable, nutrient rich, lighter color, lower viscosity, oil.
  • additive non-polar lipids and/or nutraceutical oils such as DHA, or other beneficial additives as more fully described below, which also assist in providing for certain beneficial combinations of a more bioavailable, nutrient rich, lighter color, lower viscosity, oil.
  • the disclosure also includes a method for production of a low chlorophyll content oil composition
  • a method for production of a low chlorophyll content oil composition comprising the steps of obtaining an algal paste; extraction of the algal paste with an alcohol to form an alcoholic extract of algal lipids; extraction of the obtained alcoholic extract with, e.g., an organic solvent such as the hydrocarbons hexane or heptane, to separate the fraction of non-polar lipids, transferring the alcohol layer containing pigments and polar lipids to a further stage of processing; adding water to the alcohol layer extracted, e.g., with heptane, and then its sequential extraction with, e.g., heptane, to extract the pigment fraction and separating out the polar lipid fraction.
  • an organic solvent such as the hydrocarbons hexane or heptane
  • Polar lipids can then be obtained from the fraction containing them by evaporation, and pigments can also be obtained by evaporation of the fraction containing them.
  • Polysaccharides can be obtained from the fraction containing them by subjecting the fraction to a short winterization stage. Further, chlorophyll may be removed from the fraction containing them through the use of suitable bleaching materials.
  • the disclosure also includes an alternative method for production of a low chlorophyll content oil composition
  • a low chlorophyll content oil composition comprising the steps of obtaining an algal oil or extract which includes both polar and non-polar lipid fractions and also has a chlorophyll concentration.
  • the method further includes using polarity characteristics of the polar and non-polar lipid fractions to segregate polar from non-polar components in the algal oil or extract, including substantially segregating the chlorophyll concentration with the non-polar lipid fraction. Additional steps include bleaching out substantially all the chlorophyll concentration from the non-polar containing fraction; and re- combining the polar and non-polar lipid fractions to produce the low chlorophyll-content oil composition
  • FIG. 1 discloses a schematic diagram of extraction and bleaching process steps for an exemplary method of preparation of the oil of an embodiment of the disclosure.
  • FIG. 2 is a photographic depiction of an embodiment of a composition of the disclosure having a desired target polar lipid, glycolipid and chlorophyll concentration, bioavailability, color and viscosity of an oil composition, an embodiment of which is disclosed herein.
  • FIG. 3 is a photographic depiction of a powder obtained by an embodiment of a process of the disclosure made up substantially of non- lipids components comprising, e.g., polysaccharides contained in the crude ethanolic algal extract made according to an embodiment of the process as described herein.
  • FIG. 4 is a graphical depiction of a spectral characterization of an embodiment of an ethanolic extract of Nannochloropsis and products after pigments removal as discussed in Example 1 .
  • FIG. 5 is a graphical depiction of a UV-Visible spectral characterization of an embodiment of an algal extraction as discussed in Example 2.
  • polar lipids means amphiphilic lipids with a hydrophilic head and a hydrophobic tail.
  • polar lipids include phospholipids and glycolipids.
  • non-polar lipids means fatty molecules wherein the charge distribution is largely evenly distributed, and the molecules do not have positively and negatively charged ends.
  • non-polar lipids include triglycerides of the various fatty acids in the oil (e.g., EPA, palmitoleic acid and others).
  • an algal extract which presents as a dark green or even black highly viscous oil can be obtained.
  • Procedures for obtaining the algal biomass extract, and starting algae and extraction procedures for preparing the algal biomass can include the following steps:
  • an algal paste such as a Nannochloropsis or Chlorella algal paste
  • extraction of the algal paste with an alcohol such as an ethyl alcohol to form an alcoholic extract of algal lipids with a low water content (forming, e.g., an ethanolic extract of Nannochloropsis lipids (hereinafter referred to as “EEN” for brevity); extraction of the obtained EEN with, e.g., an organic solvent such as the hydrocarbons hexane or heptane to separate the fraction of non-polar lipids (e.g., triglycerides, waxes, carotenes), thus forming a “non-polar lipid fraction (F#1 of FIG. 1 ) in the heptane layer.
  • the alcohol layer contains pigments and polar lipids and can be transferred to a further stage of processing. See FIG. 1 .
  • the next stage of processing can involve adding water to the alcohol layer extracted, e.g., with heptane and then its sequential extraction with, e.g., heptane, to extract the pigment fraction (see FIG. 1 , heptane layer, F#3) and separating out the polar lipid fraction (see FIG. 1 , water-alcohol layer, F#2).
  • Polar lipids can be obtained from the F#2 fraction by evaporation, and pigments can be obtained by evaporation of the F#3 fraction.
  • the F#1 layer may contain an amount of chlorophylls and carotenoids, which can be removed by methods known to those skilled in the art, e.g., methods known for the production of edible oils.
  • Examples of these methods include adsorption-filtration using silica gel, bleaching clays such as B80, T41 , activated carbon, and others.
  • adsorption-filtration using silica gel bleaching clays such as B80, T41 , activated carbon, and others.
  • the extracted lower layer contained clarified polar lipids (F#2).
  • This fraction can be polished by 3g of, e.g., Amaze-N bleaching sorbent, from Helix Chromatography (15 E. Palantine Rd. #1 18, Prospect Heights, IL 60070; helixchrom.com), or similar sorbents (if needed).
  • Example 1 the products shown in Example 1 can be broken down into three fractions of the incoming ethanolic extract of Nannochloropsis - 1 ) Fraction (F#1 ), non-polar lipids, mainly triglycerides; 2) Fraction (F#2), polar lipids, including glycolipids and phospholipids; and Fraction (F#3), a fraction of medium polarity, comprising di- and mono-glycerides, free fatty acids (FFA’s), carotenoids and chlorophyll.
  • the clarified F#1 and F#2 fractions can be used as sources of valuable lipids high in palmitoleic and eicosapentaenoic acids (EPA).
  • Fractions F#1 -3 can each be used as food additives and are valuable raw materials with high biological potential.
  • a sample of a dark green paste of the algal biomass was prepared generally in accordance with a method outlined in U.S. Pat. No. 8,591 , 912 B1 (see, generally, Col. 6, line 62 to Col. 9, line 3).
  • the algal biomass paste was extracted with hot absolute ethanol. Specifically, 66 g algal paste, 3x250 mL ethanol, at 75°C, 30’ while stirring at 500 rpm each, centrifugal separation at 4450 rpm for 10 minutes, yielded a specimen algal extract.
  • glycolipids diogalactosyl diglycerides (MGDG) and digalactosyl diglycerides (DGDG) and 2) phospholipids (phosphatidlycholine, phosphatidylethanolamine, and phosphatidylinositol) (See Table 4, herein.)
  • MGDG monoogalactosyl diglycerides
  • DGDG digalactosyl diglycerides
  • phospholipids phosphatidlycholine, phosphatidylethanolamine, and phosphatidylinositol
  • Chlorophylls were bleached from the remaining non-polar lipid components using well developed protocols for vegetable oil bleaching generally as described in Example 1 above; and, e.g. 1 gram of silica gel was added to the entire heptane layer obtained and, after vigorous stirring for 5 minutes, the slurry was filtered through a layer of one gram of silica gel (instead of silica gel, activated carbon or T41 bleaching clay can be used). Due to variations in the properties of various silica gels, activated carbons, and bleaching clays, the actual amounts of the materials should generally be adjusted on plant.
  • a bioavailable polar lipid-rich, low chlorophyll-containing oil composition having a generally low viscosity and with a nearly clear to light brown color was obtained. See FIG. 5 for spectral analysis.
  • the composition was a waxy solid at ambient temperature of @ 70 degrees Fahrenheit. The composition melts when warmed and exhibits low viscosity when blended with other oils such as triglycerides and the like.
  • the weight% of the polar lipid fraction of the total lipid concentration of the produced oil exceeds 20%, preferably exceeds 30%, more preferably exceeds 40%, even more preferably exceeds 50%, and still more preferably is about 70% or above.
  • the weight% of the chlorophyll concentration in the oil product is less than 4% of the weight of the total oil product, more preferably, it is less than 3.0%, yet more preferably, it is less than 2.0%, even more preferably, it is less than 1 .0%, and still more preferably, it is about 0.1 % or below.
  • the weight% of the polysaccharides concentration in the oil product is about 4% or less of the weight of the total oil product, more preferably, it is less than 3.0%, yet more preferably, it is less than 2.0%, even more preferably, it is less than 1.0% or below.
  • the weight% of glycolipids as a weight% of total polar lipids exceeds 20%, preferably exceeds 30%, more preferably exceeds about 40%, even more preferably exceeds 50%, and still more preferably it is about 60% or above, and its weight% of the total oil composition exceeds 10%, more preferably 20%, and still more preferably is about 25% or above.
  • the weight% of phospholipids as a weight% of polar lipids exceeds 20%, more preferably exceeds 30%, and still more preferably exceeds 35%, and their weight% of the total oil composition exceeds 20%, more preferably 30%, and still more preferably 40%. While not being bound by any particular theory, applicant believes that by the combination of these characteristics, including very low chlorophyll concentration in the oil product, an attractive, lightly colored, nearly clear, to amber, up through darker amber color is produced. Also, EPA concentration of the total oil product content is at least 20 weight%, more preferably at least 25%, and still more preferably at least about 30 weight% or greater is produced. Similarly, the omega 3 content of the oil product is at least 20 weight%, more preferably at least 25 weight%, and still more preferably at least about 30 weight% or greater is produced. Elevated bioavailability of the resultant oil is also achieved.
  • powders of non-lipids components such as polysaccharides of the crude ethanolic algal extracts. See FIG. 3.
  • the weight% of the chlorophylls of the composition is less than 4%, preferably less than 3%, yet more preferably less than 2%, even more preferably less than 1 %, still more preferably less than 0.5%, and still even more preferably less than about 0.1% of the total weight% of the composition.
  • the composition has an enhanced weight% of several other ingredients, including carotenoids, e.g., carotenes ( ⁇ and ⁇ ), and zeaxanthins (yellow pigments), and canthaxanthin and zeaxanthin (reddish pigments), with total carotenoids making up more than 0.5% of the total weight of the extract and preferably more than 1 %.
  • carotenoids e.g., carotenes ( ⁇ and ⁇ ), and zeaxanthins (yellow pigments), and canthaxanthin and zeaxanthin (reddish pigments
  • the bioavailable, high polar-lipids containing, EPA-containing, low chlorophyll content oil compositions can be presented as formulations in which other useful ingredients are added. These other useful ingredients can be added alone, or in one or more combinations, e.g., combinations with other essential oils, dietary supplements, health supplements and the like.
  • omega 3 containing oils or components such as DHA and EPA (e.g., in the form of the neutral lipids extracted as a product in the instant invention or externally sourced), the lysolipids from the instant invention, or externally sourced, ethyl esters of DHA or EPA; 2) antioxidants such as carotenoids, including astaxanthin, lutein, zeaxanthin, lycopene, carotenes (alpha and beta), cryptoxanthin, and mixture thereof (including the carotenoid fraction of the instant invention); 3) vitamins, such as vitamin C and D; 4) cannabinoids, such as cannabidiol (CBD), and 5) other combinations.
  • DHA and EPA e.g., in the form of the neutral lipids extracted as a product in the instant invention or externally sourced
  • ethyl esters of DHA or EPA ethyl esters of DHA or EPA
  • antioxidants such as carotenoids, including astax
  • formulations including some of these species with less-colored and/or less-viscous compositional profiles, may reduce the overall color profile and viscosity of formulations which include the fatty acid compositions with high polar lipid, high glycolipid, and low chlorophyll concentrations prepared by embodiments of the processes disclosed herein. Thus, this may be achieved, e.g., by inclusion of non-polar lipids, either added back in from original biomass stock, or from an external source, or by preparation of formulations which demonstrate such attributes.
  • nutraceutical formulations including blends of the polar EPA fraction described above with DHA (omega 3) can beneficially be in a ratio from 10-90 to 90-10, wherein preferable levels of the polar EPA formulation component being mixed at 20-50%.
  • Uses for such a formulations include both use as a key food supplement/nutraceutical in its own right for cardiovascular health, mood, anti-depression and more, and also as a delivery system for other neutral lipids and components it is formulated with. This can be DHA, other neutral forms of EPA, or mixtures thereof.
  • Astaxanthin at levels of 10-60% can also be beneficially formulated, with preferable levels at 10-30%, either with pure polar EPA lipids or blends thereof with neutral EPA and/or EPA.
  • Another component that could be beneficially added to such a formulation is coenzyme Q10 at levels of around 1 -50%, preferably about 2-20% on the polar EPA, either pure or in any of the above formulations.
  • formulation blends with added neutral lipids can be useful to target various viscosity levels, such as 50,000 cps, preferably less than 10,000 cps, more preferably less than about 2,000 cps, and most preferably, about 300 cps or less.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Fats And Perfumes (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Organic Insulating Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne une composition d'huile biodisponible dans laquelle au moins 20 % en poids de sa teneur totale en lipides comprend des lipides polaires tels que des glycolipides ou des phospholipides, au moins 30 % en poids de ses lipides polaires comprend des glycolipides, et pas plus de 4 % en poids de la composition d'huile est constituée d'espèces de chlorophylle. L'invention concerne également des formulations contenant lesdites compositions d'huile et des procédés de production desdites compositions d'huile à partir d'huiles ou d'extraits d'algues.
PCT/US2020/061561 2020-11-20 2020-11-20 Compositions contenant des oméga-3 améliorées WO2022108595A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2023530197A JP2023548424A (ja) 2020-11-20 2020-11-20 改善されたオメガ－３含有組成物
MX2023005910A MX2023005910A (es) 2020-11-20 2020-11-20 Composiciones que contienen omega-3 mejoradas.
CA3198736A CA3198736A1 (fr) 2020-11-20 2020-11-20 Compositions contenant des omega-3 ameliorees
IL303067A IL303067A (en) 2020-11-20 2020-11-20 Preparations containing improved omega 3
EP20962632.4A EP4247924A1 (fr) 2020-11-20 2020-11-20 Compositions contenant des oméga-3 améliorées
KR1020237020521A KR20230107344A (ko) 2020-11-20 2020-11-20 개선된 오메가-3 함유 조성물
PCT/US2020/061561 WO2022108595A1 (fr) 2020-11-20 2020-11-20 Compositions contenant des oméga-3 améliorées
CN202080108322.1A CN116723827A (zh) 2020-11-20 2020-11-20 改进的含ω-3的组合物
AU2020477490A AU2020477490A1 (en) 2020-11-20 2020-11-20 Improved omega-3 containing compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2020/061561 WO2022108595A1 (fr) 2020-11-20 2020-11-20 Compositions contenant des oméga-3 améliorées

Publications (1)

Publication Number Publication Date
WO2022108595A1 true WO2022108595A1 (fr) 2022-05-27

Family

ID=81709521

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2020/061561 WO2022108595A1 (fr) 2020-11-20 2020-11-20 Compositions contenant des oméga-3 améliorées

Country Status (9)

Country Link
EP (1) EP4247924A1 (fr)
JP (1) JP2023548424A (fr)
KR (1) KR20230107344A (fr)
CN (1) CN116723827A (fr)
AU (1) AU2020477490A1 (fr)
CA (1) CA3198736A1 (fr)
IL (1) IL303067A (fr)
MX (1) MX2023005910A (fr)
WO (1) WO2022108595A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015518A1 (fr) * 2001-08-13 2003-02-27 E.I. Du Pont De Nemours And Company Procede permettant de lutter contre des insectes nuisibles particuliers par application de composes d'anthranilamide
WO2010027258A1 (fr) * 2008-09-02 2010-03-11 N.V. Nutricia Compositions nutritionnelles avec globules lipidiques avec un noyau comprenant des lipides végétaux et un revêtement comprenant des phospholipides ou des lipides polaires
UZ4370C (fr) * 2009-02-02 2011-07-29
US20120029184A1 (en) * 2010-04-06 2012-02-02 Heliae Develoopment, LLC Methods of and systems for isolating carotenoids and omega-3 rich oil products from algae
RU2512375C1 (ru) * 2012-11-13 2014-04-10 Дмитрий Лелич Дружинин Пищевая водно-липидная композиция, содержащая каротеноиды
US20140242238A1 (en) * 2013-02-28 2014-08-28 Kiran L. Kadam Algae extraction process

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003015518A1 (fr) * 2001-08-13 2003-02-27 E.I. Du Pont De Nemours And Company Procede permettant de lutter contre des insectes nuisibles particuliers par application de composes d'anthranilamide
WO2010027258A1 (fr) * 2008-09-02 2010-03-11 N.V. Nutricia Compositions nutritionnelles avec globules lipidiques avec un noyau comprenant des lipides végétaux et un revêtement comprenant des phospholipides ou des lipides polaires
UZ4370C (fr) * 2009-02-02 2011-07-29
US20120029184A1 (en) * 2010-04-06 2012-02-02 Heliae Develoopment, LLC Methods of and systems for isolating carotenoids and omega-3 rich oil products from algae
RU2512375C1 (ru) * 2012-11-13 2014-04-10 Дмитрий Лелич Дружинин Пищевая водно-липидная композиция, содержащая каротеноиды
US20140242238A1 (en) * 2013-02-28 2014-08-28 Kiran L. Kadam Algae extraction process

Also Published As

Publication number Publication date
AU2020477490A1 (en) 2023-06-29
KR20230107344A (ko) 2023-07-14
CN116723827A (zh) 2023-09-08
CA3198736A1 (fr) 2022-05-27
IL303067A (en) 2023-07-01
JP2023548424A (ja) 2023-11-16
MX2023005910A (es) 2023-05-26
EP4247924A1 (fr) 2023-09-27

Similar Documents

Publication Publication Date Title
Lemahieu et al. Impact of feed supplementation with different omega-3 rich microalgae species on enrichment of eggs of laying hens
Świątkiewicz et al. Application of microalgae biomass in poultry nutrition
Kovač et al. Algae in food and feed
Gouveia et al. Evolution of pigment composition in Chlorella vulgaris
Gupta et al. Studies on physico-chemical characteristics and fatty acid composition of wild apricot (Prunus armeniaca Linn.) kernel oil
US11298387B1 (en) Omega-3 containing compositions
WO2007067207A1 (fr) Forme stabilisee d'huile de poisson
DE4219360A1 (de) Verfahren zur Gewinnung von Lipiden mit einem hohen Anteil von langkettig-hochungesättigten Fettsäuren
CA2694054A1 (fr) Composition enrichie en acides gras de type omega 3
JP2003505007A (ja) 卵黄からリン脂質を選択的に除去するための水抽出プロセス
US20100196424A1 (en) Stabilization of long chain polyunsaturated oils
US20170281564A1 (en) Therapeutic astaxanthin and phospholipid composition and associated method
Spasevski et al. Fatty acid composition and β-carotene content in egg yolk of laying hens fed with linseed, paprika and marigold
Kralik et al. The effect of vegetable oils and the fish oil on the fatty acid profile in egg yolks
Topuz et al. Characterization and emulsifying properties of aquatic lecithins isolated from processing discard of rainbow trout fish and its eggs
CN107308029A (zh) 可食用的雨生红球藻天然口红及其制备方法
WO2022108595A1 (fr) Compositions contenant des oméga-3 améliorées
US20210214711A1 (en) Method for obtaining fat-soluble and water-soluble compounds from microalgae by modulating the polarity of vegetable or animal oils
Molla et al. Extraction and characterization of oil and lecithin from Boal (Wallago attu) fish
RU2162647C2 (ru) Способ обогащения рыбного жира биологически активными веществами из беспозвоночных гидробионтов
Hoa et al. Research of the composition of lipids, fatty acids, and amino acids from egg and body of sea urchin Tripneustes gratilla
JP2020011927A (ja) アスタキサンチン含有粉末
US11638731B2 (en) Medical compositions with Omega-3 containing excipients
JP2020502993A (ja) 海洋微細藻類を基にした食物又はドリンク
RU2740804C1 (ru) Корм для кур-несушек

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20962632

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 3198736

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2023530197

Country of ref document: JP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112023009773

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 20237020521

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112023009773

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20230519

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2020962632

Country of ref document: EP

Effective date: 20230620

ENP Entry into the national phase

Ref document number: 2020477490

Country of ref document: AU

Date of ref document: 20201120

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 202080108322.1

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 523440829

Country of ref document: SA